Search Results
Viewing: 331-340 of 3169 | All
DISCOVERYx 2021
The fifth annual DISCOVERYx program was showcased virtually on June 23 and June 30, with three presentations shown each day. Following each talk, speakers answered attendees questions during live Q&A sessions.
"This Month in Muscular Dystrophy"
Hosted by Kevin Flanigan, MD, "This Month in Muscular Dystrophy" podcasts highlight the latest in muscular dystrophy and other inherited neuromuscular disease research.
Article
Joanne Turner
Joanne Turner, PhD, is the chief scientific officer and the interim director of the Center for Microbe and Immunity Research at the Abigail Wexner Research Institute at Nationwide Children's Hospital. She is also an Elizabeth M. and Richard M. Ross Endowed Chair in Pediatric Research. Dr. Turner’s research focuses on immunity to mycobacterial infection in relation to aging.
News
2013 Technology Showcase Presented by The Research Institute at Nationwide Children's Hospital
The Office of Technology Commercialization in The Research Institute at Nationwide Children’s Hospital will present the “2013 Technology Showcase” Thursday, March 14, 2013 from 1 to 4 p.m.
News
New Study Finds Low Transfer Rates of Pediatric Burn Patients in the U.S.
According to a new study from researchers in the Center for Pediatric Trauma Research and the Center for Injury Research and Policy at Nationwide Children’s Hospital, nearly 127,000 kids in the U.S had burn injuries in 2012.
News
Researchers Identify Potential Prenatal Biomarkers of Congenital Heart Diseases
In a research letter recently published in Circulation Research, researchers at Nationwide Children’s describe a potential biomarker that would identify the presence of SVHD in a fetus based on a maternal blood test.
News
FDA Approves First Gene Therapy Treatment for Duchenne Muscular Dystrophy Developed at the Abigail Wexner Research Institute at Nationwide Children’s Hospital
Today, the Abigail Wexner Research Institute at Nationwide Children’s Hospital praised the Food and Drug Administration (FDA) for its accelerated approval of SRP-9001/ELEVIDYS for Duchenne muscular dystrophy (DMD) following decades of research in its Center for Gene Therapy to help patients with neuromuscular diseases.
Article
Hematopoietic Stem Cell Transplant
Hematopoietic stem cells in the blood that may have many other applications to treat more than just cancers of the blood. Our team uses hematopoietic stem cell transplant clinical trials to find faster and more personalized tactics solutions for multiple different kinds of cancers throughout the
Article
Other/Multiple Specialties
These trials involve finding solutions for patients who have more than one condition involving hematology, oncology, & bone and marrow transplant. Multispecialty studies focus on new ways to treat the whole patient through by studying the correlations between different diseases.
Article
Garg Lab
Under the direction of Vidu Garg, MD, the Garg Lab focuses on identifying the genetic contributors to congenital heart defects.